| __timestamp | ImmunityBio, Inc. | Taro Pharmaceutical Industries Ltd. |
|---|---|---|
| Wednesday, January 1, 2014 | 4326000 | 91733000 |
| Thursday, January 1, 2015 | 226206000 | 87644000 |
| Friday, January 1, 2016 | 94391000 | 92365000 |
| Sunday, January 1, 2017 | 53821000 | 85656000 |
| Monday, January 1, 2018 | 35463000 | 88196000 |
| Tuesday, January 1, 2019 | 46456000 | 89971000 |
| Wednesday, January 1, 2020 | 71318000 | 93413000 |
| Friday, January 1, 2021 | 135256000 | 91355000 |
| Saturday, January 1, 2022 | 102708000 | 113676000 |
| Sunday, January 1, 2023 | 129620000 | 198366000 |
| Monday, January 1, 2024 | 218935000 |
Data in motion
In the ever-evolving pharmaceutical industry, understanding the efficiency of Selling, General, and Administrative (SG&A) expenses is crucial. ImmunityBio, Inc. and Taro Pharmaceutical Industries Ltd. offer a fascinating comparison over the past decade. From 2014 to 2023, ImmunityBio's SG&A expenses fluctuated significantly, peaking in 2015 with a staggering 2,262% increase from the previous year. Meanwhile, Taro maintained a more stable trajectory, with expenses growing by approximately 115% over the same period.
By 2023, Taro's SG&A expenses reached nearly double those of ImmunityBio, highlighting its expansive operational scale. However, the data for 2024 is incomplete, leaving room for speculation on future trends. This analysis underscores the importance of strategic financial management in maintaining competitive advantage in the pharmaceutical sector.
Eli Lilly and Company vs Taro Pharmaceutical Industries Ltd.: SG&A Expense Trends
Novo Nordisk A/S or Taro Pharmaceutical Industries Ltd.: Who Manages SG&A Costs Better?
Who Optimizes SG&A Costs Better? Novartis AG or Taro Pharmaceutical Industries Ltd.
Who Optimizes SG&A Costs Better? Sanofi or ImmunityBio, Inc.
Who Optimizes SG&A Costs Better? Alnylam Pharmaceuticals, Inc. or ImmunityBio, Inc.
Who Optimizes SG&A Costs Better? Genmab A/S or Taro Pharmaceutical Industries Ltd.
Summit Therapeutics Inc. vs Taro Pharmaceutical Industries Ltd.: SG&A Expense Trends
Who Optimizes SG&A Costs Better? Bio-Techne Corporation or ImmunityBio, Inc.
Breaking Down SG&A Expenses: Xenon Pharmaceuticals Inc. vs ImmunityBio, Inc.
ImmunityBio, Inc. or Soleno Therapeutics, Inc.: Who Manages SG&A Costs Better?
Breaking Down SG&A Expenses: Agios Pharmaceuticals, Inc. vs Taro Pharmaceutical Industries Ltd.
Selling, General, and Administrative Costs: Taro Pharmaceutical Industries Ltd. vs Xencor, Inc.